interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Indocyanine Green

Generic competition · all medicines · read 12 November 2026

Is there a generic of Indocyanine Green, and who makes it?

Indocyanine Green appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 2 generic makers listed as marketed across them. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Indocyanine Green3 dosage-form groups in the Orange Book
2generic makers listed
  1. Indocyanine Green appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 2 generic makers listed as marketed across them.
  2. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Injectable, Injection

One to three generic makers listed

Brand listed as marketed: Ic-Green. 2 generic makers with 2 generic products listed as marketed; the first generic approval is dated 21 November 2007.

20052010201520202025203002Renew Pharmaceuticals Ltd, first approval 21 November 2007Zydus Lifesciences Global Fze, first approval 3 August 2026data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Renew Pharmaceuticals Ltd21 November 20071
Zydus Lifesciences Global Fze3 August 20261

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Powder, Intravenous, Interstitial

Brand listed, no generic listed as marketed

Brand listed as marketed: Spy Agent Green Kit. No generic is listed as marketed.

20152020202520302035204001brand 2018data datePatent 8185176 listed to expire 4 June 2028Patent 8647605 listed to expire 11 February 2029Patent 8406860 listed to expire 9 April 2029Patent 10631746 listed to expire 4 August 2035Patent 11712320 listed to expire 14 July 2039
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 4 June 2028Patent 8185176
  • 11 February 2029Patent 8647605
  • 9 April 2029Patent 8406860
  • 4 August 2035Patent 10631746 drug product
  • 14 July 2039Patent 11712320 drug product

Solution, Intravenous, Interstitial

Brand listed, no generic listed as marketed

Brand listed as marketed: Zyogreen. No generic is listed as marketed.

20202025203001brand 2026data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.